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An important procedure for providing information concerning the  site of 
development of various types of immune response, and the manner in which 
they are put into effect, involves the passive transfer of immunity to normal 
individuals. It is now widely believed that the destructive reaction of indi- 
viduals against vascularized solid tissue homografts is put into effect by im- 
munologically "activated"  cells  of  the  lymphocytic series,  rather  than  by 
humoral antibodies (I, 2). For several years this concept rested principally upon 
evidence that homograft sensitivity could only be transferred passively (more 
correctly "adoptively") by means of living cells obtained from the lymph nodes 
or spleens of specifically immunized animals (3-5), Nevertheless, a well recog- 
nized weakness of this thesis was the failure of attempts to transfer sensitivity 
by means of whole blood, leucocyte concentrates, or peritoneal exudates (3-5). 
Subsequent evidence that the lymphocyte population of the blood of birds and 
mammals includes immunologically competent elements (6-9) hinted that this 
failure may merely have reflected shortcomings of technique, such as lack of 
sensitivity, rather than the absence of cells capable of transferring immunity. 
The findings of Gowans et al.  (9) and our own preliminary observations (i0) 
have shown this to be the case. 
This paper presents the results of studies principally designed to compare, 
on a quantitative basis, the capacity of lymph node cells, whole blood, leucocyte 
concentrates, thoracic duct lymphocytes and peritoneal exudate ceils to trans- 
fer  skin homograft sensitivity in mice and rats.  Additional experiments  are 
reported which were designed to determine the time of appearance and per- 
sistence of immunologically "activated" cells,  capable  of transferring sensi- 
tivity,  in  the  regional  nodes  and  blood  of  recipients  of  orthotopic  skin 
homografts. 
Principle  of the Experiments.--There  are two not unrelated methods for demon- 
strafing the competence of cellular inocula to transfer homograft immunity adoptively 
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between members of an inbred strain (see Fig. 1). In the first method (3, 4) lymphoid 
cells from donors that have been specifically immunized in respect of the transplanta- 
tion isoantigens of an alien strain are inoculated into normal, isologous recipients which 
are subsequently challenged with test-skin homografts from the same foreign strain. 
Accelerated rejection of these  grafts,  as a  consequence of a  "second set"  reaction, 
furnishes evidence of the transfer of sensitivity. 
S 
ALLEN STRAIN 
MICE 
~.~ 
Immunization  by means of 
skin homograft  from alien strain 
j~ ~  Test skin homograft 
from alien strain 
,) ) )'  ~ 
t  ~,  recipient 
Cell transfer 
Donor  of Isologous 
lymphoid cells 
Long established  alien 
strain skin homograft 
~'~  Isologous 
recipient 
Fig. 1.  Illustrating  the two methods for demonstrating  the competence of cellular inocula 
to transfer homograft sensitivity adopfively. 
The second method (11)  requires animals previously rendered specifically tolerant 
of test skin homografts from the alien donor strain. Abolition of tolerance, as evidenced 
by destruction of hitherto normal, healthy looking tolerated skin homografts of long 
standing,  can be effected in either of two ways:--(a)  by transfer  of lymphoid cells 
from a normal isologous donor, or (b) by transfer of lymphoid cells from an isologous 
donor previously sensitized  in respect  of the  transplantation  antigens  of the  alien 
strain. Either way, the immunological shortcomings of the tolerant animal are  made 
good. However, if equal numbers of lymphoid cells from normal and sensitized donors 
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time required for the abolition of the tolerant state. Furthermore, preliminary studies 
(10) have shown that this disparity in efficacy becomes greater with reduction in the 
dosage of cells transferred, until a  transfer dosage is reached at which only immuno- 
logically "activated"  cells have any detectable  influence. Cell transfers  to  tolerant 
recipients, at a  dosage level where normal cells are ineffective, provide the basis of an 
all-or-nothing test system for indicating the presence of cells capable of transferring 
homograft sensitivity. 
The test system provided by tolerant hosts was employed for most of the experi- 
ments to be described, partly because it eliminates the possibility that the sensitivity 
manifested by these animals could have been caused by their active immunization in 
response  to  inadvertently  transferred  antigen,  but  principally  on  account  of  its 
superior sensitivity. 
Materials and Methods 
The subjects of our experiments were animals of both sexes, belonging to domestic isogenic 
sublines of mouse strains A and CBA, and of the Lewis and B.N. rat strains. 
The median survival times, together with their standard errors,  of skin homografts ex- 
changed between normal adult animals in the various donor/recipient strain combinations 
employed were as follows: 
Mice: CBA --* A 
A --* CBA 
Rats: B.N. --* Lewis 
Lewis --* B.N. 
10.2 :h 0.3 days (12) 
11.0 q-- 0.3 days (12) 
10.2 -4- 0.8 days (13) 
10.0 :h 0.9 days (13) 
Some  of the tolerant mice used were by-products of  an investigation of  the tolerance- 
conferring capacity in newborn mice of different types and dosages  of homologous  cellular 
inocula (14). Tolerance was conferred upon the remainder by the intravenous injection at 
birth with 10 million CBA/A hybrid spleen cells. Tolerant rats were obtained by neonatal 
intravenous injection with 60 million homologous bone marrow cells. 
All neonatally inoculated animals were challenged with donor strain skin grafts when they 
were 8 to 10 weeks old. Only those which were classified as "highly tolerant", i.e. still bore 
healthy skin homografts with normal fur crops on the 50th postoperative day, were used as 
hosts for transfer experiments. 
Previous work has shown that  less  than  10 per cent of A  strain mice rendered highly 
tolerant of CBA skin grafts normally lose their tolerant status of their own accord, as evidenced 
by destruction of their test grafts, during the ensuing 100 days (14, 15). This constitutes the 
justification for maintaining tolerant animals under close observation for at least 100 days 
after cell transfer. 
Sensi~izat¢on of isologous donors was  accomplished  in both mice and rats  by means of 
orthotopic skin homografts transplanted to the right sides of the animals' chests (16), followed 
in certain designated experiments by the intraperitoneal inoculation of living homologous 
splenic cells. In a few experiments conducted upon mice an intraperitoneal  injection of splenic 
cells constituted the only immunizing  stimulus. 
Blood was obtained by cardiac puncture and pooled,  using heparin as an anticoagulant. 
Leucocytes  (or,  more  correctly,  leucocyte concentrates, since the  preparations inevitably 
included erythrocytes) were obtained by resuspending the buffy coat of the blood in phosphate- 
buffered Ringer's solution. 
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kept at 4°C pending injection. Only the axillary and brachial nodes were used since these are 
the draining or regional nodes for skin grafts placed upon the lateral thoracic wall (3). 
Transfer of cells from sensitized isologons donors to tolerant mice was carried out on the 
11th postoperative day if sensitization had been effected  by skin homografts; i.e., at a  time 
when destruction of the grafted tissue was almost complete.  When splenic ceils constituted the 
only antigenic stimulus, or when they constituted a  "booster" stimulus, cell transfers were 
carried out 8 days after their inoculation since intraperitoneally  admimstered cells are known 
to evoke sensitivity much more promptly than orthotopic skin grafts (17). 
In rats, cells were transferred 10 days after a booster injection of 150 million spleen cells. 
Unless otherwise stated, all inocula were transferred to tolerant mice by the intraperitoneal 
route, and to rats by the intravenous route. 
Millipore diffusion chambers were constructed with VC nitrocellulose  membranes (Millipore 
Filter Corp.,  Bedford,  Massachusetts) having a pore size of 100 nap and a thickness of 130/~. 
These were bonded with MF No. 1 cement (Millipore  Filter Corp.) onto lucite rings (UVA 
plexiglass: 14 mm OD X  10 mm ID X  2 mm thickness) each bearing a single access hole. The 
space within each chamber was 147 mmL Before use, the assembled chambers were sterilized 
with ethylene oxide. After suspensions of cells had been inoculated into these chambers, with 
the aid of a 24G needle, v/a the access hole, the latter was sealed with duco cement. The loaded 
chambers were  then inserted intraperitoneally in mice via a  short mid-ventral incision, and 
0.5 ml Hanks' solution was introduced into the peritoneum. The abdominal muscle wall was 
then closed with continuous silk sutures, and the skin with 11 mm Michel wound clips. Not 
more than 90 minutes elapsed between harvesting the nodes and spleens and the insertion of 
the chambers intra-abdominally. 
Parabiosis in rats and mice was effected by methods described dsewhere (18). The partners 
were surgically united by their skin and abdominal musculature without a  persistent cello- 
anastomosis. When necessary, separation of the parabionts was performed by severing them 
at their parabiotic junction, care being taken not to penetrate the abdominal cavity. The 
wounds were closed with 11 mm Michel wound clips, and healing was complete within 7 days. 
Cannulation of the thoracic duct in rats was performed by a modification (19) of the method 
of Bollman, Cain, and Grindlay (20). After insertion of the cannulae the a  nimaJs were allowed 
to recover consciousness after which they were maintained in restraining eages. Lymph was 
collected  overnight into tubes containing Hanks' balanced salt solution (buffered  to pH 7.3) 
and hepaxin  (10 Iv/ml). 
Cell counts were made with the aid of a hemocytometer after which the concentration of 
the leucocytes  or lymph node cells in the suspensions was adjusted so that the desired cell 
dosage was administered in a constant volume,--about 1 ml for mice and 2.5 ml for rats. 
RESULTS 
1.  Transfer  of  Sensitivity  in  Mice  by  Means  of  Lymph  Node  Cdls.--The 
results of tests carried out with the CBA --~ A  and the A ~  CBA mouse strain 
combinations (Tables I  and II) fully confirm previous findings that when rela- 
tively high  dosages  of lymph node  ceils  are  transferred,  ceils from  sensitized 
donors abolish tolerance more rapidly and consistently than ceils from normal 
donors.  For both strain combinations there  is a  cell dosage  level at or below 
which normal node cells are almost, if not completely, incapable of prejudicing 
the well being of tolerated grafts,  whereas cells from sensitized  donors are still 
consistently effective.  For  A  strain mice  tolerant  of  CBA  grafts  this  dosage 
is about 5  million cells, whereas for CBA's tolerant  of A  tissue, it is  about  10 
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With the CBA --~ A strain combination destruction of a  tolerated graft never 
took place sooner than 8 days after transfer of activated node cells, even when 
the  maximum dosage  was employed.  Over the  dosage range  20  to  240  X  l0 s 
cells the survival times of the tolerated grafts were remarkably uniform. How- 
ever, with cell dosages below 20  X  l0  s tolerance  was abolished less rapidly in 
a  significant proportion of the subjects. 
TABLE I 
Abolition of Tolerance of CBA Skin in A Strain Mice by the Intraperitoneal Transfer 
of Isologous Node Cells 
Isologous  donors 
Status  Immunizing 
stimulus 
Normal 
Sensitized§  CBAskin 
No. of 
cells 
trans- 
ferred 
(X lOe) 
240 
120 
30 
15 
5 
240 
120 
60 
30 
20 
15 
10 
5 
Tolerant  A strain  mice 
No.  Survival  times  of  grafts 
tested  after cell  transfer  lisz* 
5 
5 
8 
6 
5 
8 
8 
12 
days 
i2 (2)t,  14 
20,  >10O (2) 
>loo (6) 
18, 19, 56,  >10o (2) 
>100 (6) 
9 (4), 10 
8 (3), io (2) 
9 (4), i0 (4) 
11 (3), 14, 17, 25 
9  (S) 
10 (2), 11 (2), 17, 18, 22 (2) 
10, 11 (3), 24, 25, 55,  >100 
15 (2), 16, 17, 19 (2), 20, 24, 25, 
39 (2), 45 
days 
12 
9 
8 
9 
12 
9 
12 
12 
21 
* Median survival time. 
Numbers in parentheses  indicate No. of animals. 
§ Suspensions of regional node cells  were prepared from sensitized  donors  11  days  after 
they had been grafted with CBA skin. 
2.  Transfer  of Immunity in Mice by Means  of Leucocytes.--The  tests  con- 
ducted  with  various  dosages  of  leucocytes  transferred  from  norma/  animals 
(Tables II and HI) indicated  that,  with both mouse strain  combinations,  the 
tolerance-abolishing  capacity of these cells is comparable to that of node cells. 
With  the  CBA  --*  A  combination  (Table  III),  leucocytes,  transferred  from 
donors 8 days after they had received a booster injection of homologous spleen 
cells,  were  just  as  effective in  abolishing  tolerance  as  cells  from  the  regional 
nodes  of donors  grafted with  homologous  skin  11  days beforehand.  It can be 
seen that leucocytes from donors  immunized  by skin followed by spleen  were 
not  perceptibly  more  effective  than  leucocytes  from  donors  immunized  by Node 
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means of a  single intraperitoneal injection of homologous spleen. This suggests 
that  the  circulating  leucocytes  of animals  which  have  just  rejected  primary 
skin homografts express the near maximal level of sensitivity evokable by any 
regimen of immunization. 
The  finding  that  as  few  as  0.63  )<  106  leucocytes  from  sensitized  donors 
abolished tolerance in most of the A strain subjects provides some indication of 
the sensitivity of the test system. 
TABLE n 
Abolition  of Tolerance of A  Strain Skin in CBA Mice by the Intraperitoneal  Transfer 
of Isologous Node Cells or Leucocytes 
Type of cell 
transferred 
Status of 
isologous 
donors* 
Leucocytes (buffy 
coat) 
Leucocytes (in  whole 
blood) 
Normal 
Normal 
Normal 
Sensitized* 
Sensitized* 
Normal 
Normal 
Normal 
Sensitized* 
Sensitized* 
Sensitized* 
402 
Tolerant CBA mice 
Survival times of tolerated A 
strain grafts after cell transfer  ~s~ 
days  days 
60, 90, > 10O (4) 
40, >10o (s) 
> 10o (3) 
12, 13 (2), 18, 19, 27 
22,  32  (2), 34,  46,  84, 
> 100 (2) 
45, 48, > 100 (4) 
> 100 (5) 
> 100 (6) 
14, 17, 18, 20, 22, 27 
14, 15, 19, 21, 29 
11, 14 (2), 15 (2), 17, 24, 
>100 
13 
34 
19 
19 
15 
* Isologous donors  were  sensitized  by means  of A  strain  skin  homografts.  Cells were 
transferred from these animals on the llth postoperative  day. 
Comparison of the tolerance-abolishing capacity of 5 million leucocytes pres- 
ent in a resuspension of the buffy coat in Ringer-phosphate,  with that of whole 
blood containing a  similar number of leucocytes, indicates  that these cells are 
equally  effective in  both  types of inocula.  Evidently  the presence  of plasma, 
containing humoral isoantibodies,  makes no demonstrable  contribution to the 
effectiveness  of leucocytes in  transferring  sensitivity--a  finding  entirely  con- 
sistent  with  previous  failures  to  abolish  tolerance  by  transfer  of putatively 
immune sera, even in massive amounts (21, 22). 
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reduced not only did  the minimum survival times  of the  tolerated  grafts in- 
crease, but the range of survival times broadened, some of the grafts surviving 
throughout the observation period. 
Throughout  the  experiments  with  mice  all  cells  were  transferred  via  the 
TABLE III 
Abolition of Tolerance of CBA Skin in A  Strain Mice by the Intraperitoneal  Transfer 
of Isologous Leucocyte Concentrates 
Isologous donors 
Status 
Normal 
Sensitized* 
Sensitized* 
Sensit~ed 
Immunizing 
stimulus 
No. of  Tolerant A strain mice 
cells 
trans- 
ferred  No.  Survival times of grafts 
(X 10~)  tested  after cell transfer  ~sT 
days 
30  3  15, >tOO (2) 
15  7  14, 15, 16, 27, 45, 73, > 100 
10  6  25, > 100 (5) 
5  l0  >100 (tO) 
CBA skin followed by  30  6 
intraperitoneal  in-  15  7 
jection of 50 X  l0  s  10  6 
CBA spleen cells  5  16 
2.5  8 
1.25  11 
0.63  7 
50 X  l0  s CBA spleen  10  2  13, 14 
cells  injected  intra-  5  3  14 (2), 15 
peritoneally 
CBA skin 
8, 11, 12, 13, 14, 15 
11 (5), 12, 20 
14, 15, 16, 18, 20 (2) 
11  (3), 13  (2), 14,  16,  19, 
21,  22,  26,  27,  32,  40, 
> 100 (2) 
18, 25, 28, 29, 43, 44,  75, 
>100 
17  (2), 18,  19, 22, 72, 96, 
> ioo (4) 
26, 28, 37 (2), 54, >100 (2) 
5  7  11, 13 (4), 15, 16 
5~  6  13 (4), 14, >  loo 
5§  6  18, 24, 34, 97, >  100 (2) 
days 
23 
13 
11 
17 
20 
36 
40 
36 
13 
13 
~30 
* Leucocytes were transferred  from these animals 8 days after inoculation of spleen cells. 
~: Aliquots of whole blood containing 5 million leucocytes were transferred intraperitoneally. 
§ Aliquots of whole blood containing 5 million leucocytes were transferred via the tail vein. 
intraperitoneal route principally as a matter of technical convenience. To ensure 
that this entailed no unnecessary loss of sensitivity on the part of the test sys- 
tem, a group of 6 tolerant A strain animals were injected intravenously, v/a the 
tail vein, with 1 ml of heparinized blood containing 5 million leucocytes, from 
an isologous donor immunized by means of a  skin homograft.  So far as they go 
the results, presented in the final line of Table III, suggest that this route may 404  TRANSFER  OF  SENSITIVITY TO SKIN  HOMOGRAFTS 
be slightly less effective than the intraperitoneal  one. It is of interest  that,  as 
with intraperitoneal  cell transfers, tolerance was not abolished in some of these 
hosts during  the  100 day observation period. 
TABLE IV 
Appearance and t~ersistence of Cells Capable of Transferring Transplantation Immunity  in 
Regional Nodes and Blood of A  Strain Mice Grafted with CBA Skin 
Transfer experiments with node cells  Transfer experiments with leucocytes 
Day of transfer 
of cells from  t 
immunized  No. of 
isologous  tolerant 
donors  hosts 
injected* 
4  6 
5  6 
6  8 
8  9 
11  12 
20  6 
40 
80  8 
120  6 
165  6 
200  6 
250  5 
370  5 
No. of 
Survival times of tolerated  Grafts  tolerant i Survival times of tolerated 
re-  hosts  grafts after cell transfer  grafts after cell transfer  jected  injected* 
days  per cent 
> 100 (6)  0  6 
> 100 (6)  0  7 
17, 23, 25, 26, 30,  62  8 
> 100 (3) 
14 (2), 34, 42 (2),  67  9 
83, >100 (3) 
15 (2), 16, 17, 19 (2),  100  15 
20, 24, 25, 
39 (2), 45 
i  39, 64, >100 (4)  33  6 
i 
6  i 
] 9,  10,  11, 80, 90,  62  9 
> 100 (3) 
11, 13, 14, 17, 26,  83  8 
i  >aoo 
40, 51 (2), 62,  67  5 
> a00 (2) 
[  50, 53, 58, 60,  67  9 
I  >1oo  (2) 
i  40,  >100  (4)  20 
i  60  (2), 80,  >  100  (2)  60  5 
days 
>loo (6) 
>loo (7) 
17, 28 (2), 29, 36, 
>10o  (3) 
! 24, 48, 80, 81, 
>100 (5) 
! ll, 13 (8), 14, 15, 16, 
>1oo (3) 
I 
14, 15, 21, 22, 
!  >100 (2) 
12, 16, 17, 19, 22, 25 
12, 14, 15, 20, 27, 
53, 70, > 100 (2) 
28, 40, 67, > 100 (5) 
30, 34 (2), 67, > 100 
28, 42, 90, > 100 (6) 
31, 77, 85 (2), >100 
Grafts 
re- 
jected 
per cent 
0 
0 
62 
44 
80 
67 
100 
78 
38 
80 
33 
80 
* Each tolerant A strain mouse received a standard intraperitoneal  inoculation of 5 million 
node cells or leucocytes from isologous donors previously immunized with CBA skin. 
3.  Time of Appearance and Persistence  of Cells Capable of Transferring Sensi- 
tivity in Regional Nodes and Blood of Mice Grafted with Homologous Skin. --The 
finding that transfer of 5 X  10  e activated regional node ceils or blood leucocytes 
almost consistently caused rejection of CBA grafts on tolerant A  strain hosts, 
whereas  the  same  dosages  of cells  from unsensitized  donors  were  ineffective, 
provided the basis of a  test for the presence of immunologically activated cells 
in nodes and blood at various times after exposure to skin homografts. 
Panels of normal A strain mice were grafted with CBA skin. At various inter- R.  E.  BILLINGHA~,  W.  K.  SILVERS,  AND  D.  B.  WILSON  405 
vals thereafter blood was collected by cardiac puncture, heparinized,  and then 
pooled. The regional nodes were also removed from these animals,  pooled, and 
cell  suspensions  prepared  therefrom.  Aliquots  of pooled blood containing  5 
million  leucocytes, or of regional  node  cell  suspensions  containing  the  same 
number of cells were then injected intraperitoneally into tolerant A strain mice. 
In the light of the previous data, rejection of a reasonable proportion of the 
hitherto tolerated grafts within 100 days of ceil transfer may be taken as evi- 
dence  of  the  presence  of immunologically  activated  cells  in  the  inoculum. 
Furthermore, the interval between cell transfer and breakdown of the tolerated 
grafts provides some indication of the residual level of sensitivity in the donors 
at the time of cell transfer. 
The results of this investigation (Table IV) indicate that not until the 6th 
day after A strain mice have received skin homografts are detectable numbers 
TABLE V 
Per Cent Epithdial  Survival in  CBA  Skin Homografls of 6 Days' Standing  Transplanted 
to A Strain Hosts 
(a) Not previously  grafted  100 (6) 
(b) Grafted with CBA skin 370 days previously  25, 50 (3) 
of "activated" cells present in their nodes and blood. At this time both leuco- 
cytes  and  regional  node  cells  seem  to  be  equally  effective in  transferring 
sensitivity. 
Although there is considerable variation between the results of the individual 
time lapse tests, taken as a  whole the findings  show that  "activated"  cells, 
capable of transferring  homograft sensitivity,  are still  demonstrable in both 
the regional nodes and the blood of animals  sensitized  more than  a year after 
they had received skin homografts. Furthermore,  the level of the sensitivity 
transferable by 5 million node cells or leucocytes seems to die away very slowly 
following this active immunization in response to skin homografts. Confirma- 
tion of the persistence of sensitivity in A strain mice,  immunized with CBA 
skin 370 days beforehand, was obtained by challenging  a panel of four of such 
animals  with "second set"  CBA skin grafts and  removing them on the 6th 
postoperative day for histological  evaluation of their epithelial survival scores 
(Table V). 
4.  Studies  on Sensitivity  Induced  by Injection  of A  strain Mice with a  Low 
Dosage of CBA Spleen Cdls.--Although dissociated suspensions  of splenic cells 
injected intraperitoneally  elicit sensitivity more rapidly than orthotopic skin 
grafts, the sensitivity evoked by the latter is of much greater duration (17, 22, 
23). Experiments have been carried out to determine whether these differences, 
resulting from differences in mode of immunization, are reflected in the capacity 
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A group of A strain mice were immunized by the intraperitoneal inocu/ation of a standard 
dosage  of 5 million CBA spleen cells; this number of cells is unlikely to be inferior to that 
present in skin homografts of the size employed to sensitize mice,--discs of skin about 1.0 
to  1.2 cm in diameter. Some of these mice were bled 5 days, 11 days, or 80 days after im- 
munization and allquots of their pooled blood, containing 5 million leucocytes,  were injected 
intraperitoneally  into panels of tolerant A strain hosts. Table VI presents the results of these 
tests together with those previously obtained by transfer of leucocytes from mice immunized 
with orthotopic skin homografts. 
Upon  comparison,  it  can  be  seen  that  whereas  immunologically activated 
cells  are  present  earlier in the  blood  of mice immunized with  suspensions of 
TABLE VI 
Comparison of Sensitivity-Transferring  Capacity of Leucocytes from A  Strain  Mice Sensitized 
with  Grafts of CBA  Skin with  That  of Leucocytes from Mice Sensitized  by Means of 
5 Million  CBA  Spleen Cells Inoculated Intraperitoneally 
Isologous donors 
Day of leucocyte  No. 
transfer after 
immunization  tested 
Tolerant A strain mice 
Survival times of tolerated CBA 
grafts after leucocyte transfer 
Antigenic stimulus 
administered 
Skin 
Spleen cells 
Skin 
Spleen cells 
Skin 
Spleen ceils 
7 
6 
i1  15 
6 
80 
days 
> loo (7) 
~9, 80, 84,  >lOO (3) 
11, 13 (8), 14, 15, 16, >too (3) 
18, 38 (2), 43 (2),  >loo 
12, 14, 15, 20, 27, 53, 70,  > loo (2) 
7O (3), 77, 84,  > 100 
splenic cells, cells with a  greater capacity to transfer sensitivity persist longer 
in  mice  immunized  with  skin  homografts.  These  results  may  be  taken  as 
corroborative  evidence that immunization with an orthotopic skin graft leads 
to a  stronger and more persistent level  of homograft immunity than immuni- 
zation with splenic cells inoculated intraperitoneally. 
5.  Transfer of Sensitivity with Peritoneal Exudate Cells.- 
To test the ability of peritoneal exudate cells to transfer sensitivity, normal A strain hosts 
were grafted with CBA skin. On the llth day, each animal was injected intraperitoneally  with 
2 ml of mineral oil. Then 2 days later, each was injected intraperitoneally  with 3 ml of dtrate- 
saline. Some of these animals were bled to test the sensitivity-transferring  capacity of their 
leucocytes.  Finally, the peritoneal fluid was collected, pooled, and the oil phase discarded (4). 
The cells suspended in the aqueous phase were  then counted. Groups of tolerant A strain 
hosts were injected intravenously  with (a) 5 million or (b) 10 million peritoneal exudate cells, 
or (c) blood containing 3 million leucocytes  obtained from some of these animals. R.  E.  BILLINGHA~  W.  K.  SILVERS,  AND  D.  B.  WILSON  407 
The results (Table VH) show that, contrary to previous findings, sensitivity 
is transferable  by means  of peritoneal  exudate  cells,  though  apparently  less 
effectively than  by leucocytes or regional  node cells. This disparity probably 
reflects the fact that a much higher proportion of cells of the lymphocytic series 
are present in blood leucocytes than  in peritoneal exudate cells. According to 
Mitchison (4) 50 to 60 per cent of the latter are mononuclear ceils. Estimates of 
the proportion of lymphocytes present in mouse blood leucocytes range from 
60 to 80 per cent (24). 
It may be noted that leucocytes from sensitized animals  that have received 
mineral oil intraperitoneally  appear to be less effective in abolishing tolerance 
than  similar cells from animals  which had not been inoculated with this sub- 
TABLE VII 
Transfer of Senslti~ty to Tolerant  A Strain Mice by Means of Peritoneal Exudate Cells 
Type  of cell transferred 
Peritoneal exudate 
Peritoneal exudate 
Leucocytes* 
No. of cells  No. of tolerant I  Survival  times  of tolerated 
transferred  mice tested  I  grafts after cell transfer 
.....  I 
millions  ~ys 
5  1  i  I 44,  58,  68,  >100  (8) 
10  30, 33, 45,  >100 (3) 
5  33  (2), 59, 66,  >100  (2) 
* These  leucocytes  (in  whole  blood)  were  obtained  from  animals  sensitized  with  skin 
homografts and  injected intraperitoneaUy with mineral oil on  the  llth postoperative day 
to facilitate collection of the peritoneal exudate cells 2 days later (see text). 
stance  (see Table III).  Although  the possibility cannot be excluded  that this 
may be a sampling error, this difference may be indicative of a disturbance in 
the normal differential leucocyte count. 
6.  Transfer  of Sensitivity  with Contralateral  Lymph Node Cdls.--It  is  well 
established  that  cells from  the  contralateral  axillary  and  brachial  nodes  are 
very much less effective in transferring  actively acquired homograft sensitivity 
of fairly recent origin than cells derived from regional nodes (3). To extend this 
work, tests were conducted in which contralateral  node cells were transferred 
to isologous tolerant hosts from A strain donors at various intervals after the 
latter had been grafted with CBA skin. The results (Table VIII) indicate that, 
whereas contralateral  node ceils removed from donors at the median survival 
time of their immunizing grafts are only just perceptibly capable of transferring 
sensitivity, cells obtained from these nodes at longer intervals after the donors 
had received skin homografts are more effective. 
To determine whether the presence of the regional nodes in actively immunized mice plays 
an important role in the maintenance of immunologically  activated cells in the blood stream, 
eight A strain mice were grafted with CBA skin on the right sides of their chests.  On the 28th 
postoperative day the regional axillary and brachial nodes were carefully excised.  54 days 408  TRANSFER  OF  SENSITMTY  TO  SKIN  HOMOGRAFTS 
later these animtds were bled and aliquots of the pooled blood containing 5 million leucocytes 
were injected intraperitoneally into 5 tolerant A strain mice bearing healthy CBA skin homo- 
grafts. 
The  survival times of these grafts after cell transfer  were 20, 23, 44, 46, 53 
days, respectively, indicating  that  the excision of the regional nodes from the 
sensitized donors did not seriously impair their ability to maintain an effective 
level of "cellular" immunity in their blood. 
These findings  sustain  the conclusion  that  although  the regional  nodes are 
the first lymphoid organs to be activated by the transplantation  of orthotopic 
skin homografts, activated status is ultimately acquired by other nodes and by 
the spleen. Although this could be due to the progressive wider distribution  of 
TABLE  VIII 
Transfer  of Homografl Sensitivity  from Secondary A  Strain Hosts,  Grafted with  CBA  Skin, 
to A  strain  Mice  Tolerant of CBA  Skin  by  Means  of Cells from  the Contralateral 
Lymph Nodes 
Interval between  grafting  isologous 
donors with CBA skin and cell 
transfer 
days 
11 
20 
40 
6O 
80 
No. tested 
Tolerant A strain mice* 
Survival times of tolerated  grafts 
days 
27, 495 s4 (2), 94, >100 0) 
39, 64, 98 (2), > loo (2) 
39 (2), so, > loo (3) 
21, 24, 35, 42, 56, >100 
27, 46, 78, 95,  >100 
* Each tolerant mouse received a suspension of 5 million node cells intraperitoneally. 
Animal  died  49  days  after  cell  transfer. 
an antigenic  stimulus emanating  from the graft,  a  more probable explanation 
is  that  it  reflects  the  spread  of sensitized  cells from one lymphoid  center  to 
another  (cf. reference 2). This interpretation  is sustained by the evidence that 
activated cells are present in both leucocytes and peritoneal exudates. 
7.  Influence of Splenectomy  on Sensitization of Secondary Donors.--It is well 
established  that  splenectomy does not  weaken  the vigor with  which  animals 
react against skin homografts  (25, 26). However, it has been shown that prior 
splenectomy enhances the capacity of lymphoid cells from rats sensitized with 
spinal cord plus Freund's adjuvant to transfer experimental allergic encephalo- 
myelitis to normal rats  (27, 28). In the light of these considerations  the influ- 
ence  of prior  splenectomy  on  the  capacity  of isologous  donor  node  cells  or 
leucocytes to transfer homograft sensitivity has been studied. 
A  strain mice were splenectomized and  100 days later sensitized with CBA skin grafts. 
On the llth postoperative day they were bled and their regional nodes excised.  Aliquots of R.  E.  BILLINGHAM,  W.  K.  SILVERS,  AND  D.  B.  WILSON  409 
pooled blood, containing S million leucocytes, or of a pooled suspension of regional nodes con- 
taining this number of cells were injected intraperitoneally into two groups of tolerant  A 
strain  hosts. The survival times of the tolerated grafts on these animals are presented in 
Table IX. 
The finding that leucocytes from splenectomized donors abolished tolerance 
less rapidly than leucocytes from donors whose  spleens were intact  suggests 
that the spleen does in fact make a  substantial contribution to the sensitized 
cell population of the blood of mice grafted with homologous skin  (cf. reference 
3). It is difficult to explain why regional node cells from splenectomized ani- 
mals were also less effective than those from donors whose spleens were intact, 
and  to  reconcile  these  findings  with  those  on  the  transferability  of  allergic 
TABLE IX 
Effect of Prior Splenectomy on Capacity of A  Strain Mice to Produce Activated Cells in Their 
Regional Nodes and Blood Following Subsequent Imraunization by Means of Orthotopic 
CBA Skin ttomografts 
Type of cell transferred* 
Leucocytes 
Leucocytes 
Regional nodes 
Regional nodes 
No 
Yes 
No 
Yes 
No. of tolerant 
mice tested 
7 
Survival times of tolerated grafts 
after cell transfer 
days 
11, 13 (8), 14, 15, 16, >i00 (3) 
18, 29,  64,  70, 80, 95,  > 100 
15 (2),  16,  17, 19 (2), 20, 24, 25, 39  (2) 
45 
20 (2), 42, s2  (2), 85 
* A standard dosage of 5 million node cells or leucocytes was transferred. 
These results, which constitute controls, have been transcribed from Tables IV and I, 
respectively. 
encephalomyelitis  from  splenectomized  and  subsequently  sensitized  rats 
(27, 28). 
8.  Attempt to Abolish Tolerance by Means of Activated Node Cells Transferred 
in  Cell-Impermeable  Millipore  Ckambers.--According  to  recent  findings  of 
Najarian and Feldman (29, 30) transfer of relatively high dosages of lymphoid 
cells,  in  cell-impermeable Millipore  diffusion  chambers,  from A  strain  mice 
actively immunized against CBA tissue, to normal A strain mice, confers height- 
ened sensitivity upon the latter in respect of subsequent grafts of CBA skin. 
In view of the potential significance of this work, it was decided to employ this 
method to try and procure rejection of CBA grafts borne by tolerant A strain 
hosts. 
Following Najarian and Feldman's (29) procedure closely, a group of A strain mice were 
grafted bilaterally with CBA skin and 2 days later injected intraperitoneally with 10 million 
CBA splenic cells. Nine days after these animals had received skin homografts, their spleens, 410  TRANSFER  OF SENSITMTY  TO SKIN IIO~OGRAFTS 
axillary,  brachial,  and  cervical nodes were excised, pooled,  and  dissociated in phosphate- 
buffered Ringer's solution containing 20 per cent PVP w/v (K-30; Antara Chemicals, Philadel- 
phia) to produce a cell suspension. Aliquots of 0.12 ml of this suspension, containing about 200 
million lymphoid cells, were introduced into a series of sterile Millipore chambers which were 
then carefully sealed. Two chambers were then inserted into the body cavities of each of five 
tolerant  A strain mice. 
The presence  of this  high  dosage of sequestered  "immune"  lymphoid cells 
produced no discernible adverse changes in the tolerated  CBA grafts during a 
54  day  observation  period.  Finally,  therefore,  each  tolerant  mouse  was  in- 
jected  intraperitoneally  with  20 million  regional node cells from an A  strain 
mouse which had been grafted with  CBA skin  11 days beforehand.  The com- 
plete destruction of all five tolerated  grafts within  8  to 9  days ruled  out any 
possibility of questioning their susceptibility to immunity of adoptive origin. 
TABLE X 
Survival  Times  of CBA  Test ttomografls on Normal  A  Strain  Mice  Following Transfer of 
Lymphoid  Cells in  Diffusion  Chambers from Immunized or Normal  Isologons Donors 
Immunological status of  No. of animals  Survival times of test skln homografts 
transferred cells  tested 
days 
Sensitized  11  10, 11 (3), 12 (4), 13, 14, 15 
Normal  3  10, 13, 14 
Because of this failure  to transfer  sensitivity  to tolerant mice by means of 
activated lymphoid ceils in diffusion chambers,  an attempt  was made to use 
almost exactly the same experimental design as that of Najarian and Feldman, 
to see whether sensitivity to CBA skin could be transferred to normal A strain 
mice by means of activated lymphoid ceils in Millipore chambers. 
Anti-CBA lymphoid cell suspensions were prepared from A strain mice as described above, 
and aliquots of 200 million cells were placed in chambers as before. Two loaded chambers were 
then inserted intraperitoneaUy into a group of normal adult  A strain  mice. To provide con- 
trois, some A strain mice received chambers containing similar numbers of lymphoid cells from 
unsensitized A strain animals. Two days after implantation  of the chambers all the mice were 
challenged with CBA skin. The dressings were removed and primary inspection of the grafts 
was carried out on the 6th postoperative  day. Grafts were subsequently  inspected at daily 
intervals, to establish their survival times. 
Both series of grafts healed in perfectly. The well being of the grafts borne 
by the putatively sensitized hosts on the 6th postoperative day, and their sur- 
vival  times  (Table  X)  indicated  that no effective sensitivity was  transferred 
under the conditions of these experiments. 
9.  Transfer  of  Homograft  Sensitivity  by  Parabiosis.--The  first  successful 
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procured  by parabiosis of mice  (cf.  reference 4,  31,  32).  Unfortunately,  this 
technique  was incapable of revealing the nature  of the  resistance factors in- 
volved. Since parabiosis has also been employed to induce tolerance of tissue 
homografts, and even to "transfer"  an established tolerant state from one ani- 
mal  to  another  of  similar genetic constitution  (cf.  reference  33),  transfer  of 
skin homograft  sensitivity to  normal  or  to  tolerant hosts  by parabiosis was 
investigated. 
TABLE XI 
Transfer of Homografl Sensitivity by Parabiosis 
Strain of 
test 
subjects 
CBA 
CBA 
CBA 
A 
A 
A 
A 
CBA 
CBA 
]~.N. 
Lewis 
Tolerant 
Of:~ 
CBA 
CBA 
A 
A 
Lewis 
B.N. 
isologous 
partner 
Ilnlnune 
Immune 
Immune 
Immune 
Immune 
Normal 
Immune 
Normal 
Immune 
Normal 
Normal 
Duration 
of psra- 
blosis 
days 
11 
17 
25 
9 
11 
__$ 
Interval between 
separation of 
parabionts and 
test grafting 
days 
7 
8 
8 
8 
42 
No. of 
test 
sub- 
jects 
10 
10 
Survival times of 
test grafts 
days 
8, 9 (3), 11 
7 (6), 8 (2) 
6 (3), 7 (2) 
6  (5), 8  (2) 
7, 8 (2), 9 (2) 
11, 13, 17 (3) 
12, 13 
16, 20 (3), 22 (2), 25 
31, 36, >50 
13 (9), 17 
20, 21, 25, 28, 29, >5( 
11, 12, 13, 15 (2) 
* Tolerant animals were maintained in parabiotic union  until rejection of hitherto toler- 
ated grafts took place. 
Transfer  of  sensitivity was  studied  in  two  different  ways. The first, employing the 
classic procedure,  simply entailed uniting a normal test subject to an isogenic, presensitized 
partner which had received a skin homograft 15 to 16 days previously. After 11 to 25 days the 
parabionts were separated and about a  week  later, after the lesions had healed, the test 
animal was challenged on its unoperated side with a skin homograft from the strain in respect 
of which its partner had been sensitized.  Accelerated  rejection of the skin graft furnished 
evidence of the transfer of sensitivity to the normal partner. The second method of studying 
transfer of sensitivity  by parabiosis required the use of tolerant animals. With these, evidence 
of the transfer of sensitivity depended upon showing that tolerated grafts were rejected mare 
rapidly following union to sensitized isologous partners than to normal ones. 
Table XI summarizes the various experiments carried out. When normal CBA 
mice were united to presensitized partners they did not acquire maximal sensi- 412  TRANSFER  OF SENSITIVITY TO SKIN I:IOMOGRAI~fS 
tivity to A  strain skin unless  the duration of parabiosis  exceeded  17  days. 
Eleven days was insufficient. Transfer of sensitivity in respect  of CBA tissue 
in A strain hosts occurred  more  rapidly since with this combination  9 days 
union sufficed. Furthermore, evidence  was obtained with A strain mice that 
sensitivity acquired  through parabiosis dies away fairly rapidly (compare sur- 
vival times of test grafts on animals grafted 8 and 42 days after severance of 
their parabiotic unions). 
As anticipated, parabiosis  of tolerant mice  or rats  with norma/  isologous 
partners resulted in destruction of their tolerated grafts. This was probably the 
combined  result of two concomitant processes.--(a)  the re-equipment  of the 
tolerant animal with a normal, functional  cellular machinery of immunological 
response,  furnished by  immunologically  competent cells "abstracted" from 
the partner's blood stream, and (b) primary sensitization  of the normal para- 
biont as a  consequence  of its presumed  chronic  perfusion  with foreign  cells 
derived from the chimeric leucocyte population of the tolerant animal, followed 
by transfer of some of the resultant immunologically  activated cells v/a the 
blood. 
Tolerance  was abrogated more rapidly when tolerant hosts were united to 
presensitized  partners,  presumably as a  consequence of the transfer, via es- 
tablished vascular anastomoses, of activated lymphoid elements. 
10.  Abolition of Tolerance of Skin Homografts in Rats by Transfer of Cells  from 
Normal  or Sensitized Donors.--Although  the experiments  carried  out on mice 
show  that  skin  homograft sensitivity is  transferable by lymph node cells, 
leucocytes,  or peritoneal exudate  ceils, they do  not identify the  cell type 
responsible. 
To make good this shortcoming,  it was necessary to turn to the rat. Small 
scale trials with both the Lewis ~  B.N. and the B.N. --+ Lewis combinations 
confirmed  that  both  node cells  and  leucocytes  transferred  from sensitized 
donors abolished tolerance more rapidly than similar cells from normal donors, 
and provided a useful indication of the order of magnitude of the cell dosages 
required  for  each  combination.  Lewis  rats  tolerant  of  B.N.  skin  seemed 
to require  the transfer of fewer lymphoid cells to abolish tolerance than B.N. 
rats tolerant of Lewis skin and were consequently selected for the definitive 
tests. 
The particular importance of the rat for this investigation is the facility with 
which its thoracic duct can be cannulated to furnish lymph containing almost 
exclusively lymphocytes (about 95 per cent of the small variety (34)). These 
cells are normally destined to enter the blood stream, maintaining its lympho- 
cyte level through their constant recirculation  from blood  to lymph v/a the 
lymph nodes  (35, 36). 
When  the  tolerance-abolishing  capacity of  suspensions  of  thoracic  duct 
lymphocytes from normal and immunized donors was compared  (Table XII), 
using Lewis hosts tolerant of B.N. skin grafts, it was found that even at dosage R.  E.  BILLINGHAM, W.  K.  SILVERS,  AND  D.  B.  WILSON  413 
levels  as low as  10 million  cells normal lymphocytes were  still  quite  effective 
in abolishing tolerance. However, the finding that at dosages of 10, 20, and 50 
million  ceils,  those  from non-sensitized  donors  were  somewhat  less  effective, 
TABLE XII 
Abolition of Tolerance of Skin Homografts in Rats by Transfer of Leucocytes, Node Cells, or 
Thoracic Duct Cells 
Cells  transferred  Results  Results 
(a)  With ceils from  normal 
isologous  donors 
No, 
(X 10  6  )  No. of 
toler- 
ant 
rats 
tested 
(b) With cells from sensitized 
isologous donors 
No. of 
Survival times of  toler-  Survival times of 
tolerated grafts  ant  tolerated grafts  rats 
tested 
days  days 
SOP  3  15, 20 (2) 
250  7  37, >lOP (6)  2  12, 40 
150  7  26, >lOP (6) 
75  4  > lOP (4)  5  19,46, 70, > lOP (2) 
3OO  2  tS (2) 
tSO  3  17 (3) 
75  4  23, 24, 30, 32  5  15, 17 (3), 25 
50 to 7C  3  14, 15, 24  4  11 (2), 12, 13 
7.5  3  72, >lop (2)  4  55, >lop (3) 
Strain com- 
bination 
Type 
Lewis--* B.N.  Leuco- 
cytes 
Nodes 
B.N --~ Lewis  Leuco- 
cytes 
Nodes 
Thoracic 
duct 
20  3  21 (3) 
10  3  21 (3) 
5  3  21, 28, 29 
70 to 90  4  14, 18, 23, 25 
50  5  13 (2), 19, 34, 42 
20  2  25, 28 
10  4  25, 28, 29, > 100 
5  3  > 100 (3) 
2.5 
10  13(3),16(2),  21 (2), 
28 (2), >lop 
5  19 (3), 20 (2) 
9  19,20  (2),21,25  (2), 
40, 54, >10o 
6  37 (3) >100 (3) 
3  70, >100(2) 
In these experiments all cells were transferred  by the intravenous  route. 
and that at lower dosages only sensitized cells were effective, indicates that the 
lymphocyte is the predominant, if not the exclusive, cell present in blood which 
is responsible for its ability to transfer homograft sensitivity  (cf.  reference 9). 
It need hardly be emphasized that  the  ability  of relatively low dosages of 
isologous thoracic duct lymphocytes from normal donors to abolish tolerance in 414  TRANSFER  O]~ SENSITIVITY TO SKIN HOMOGRAI~TS 
isologous hosts is just as valid evidence that these include immunologically 
competent cells  as the ability of thoracic duct cells  to cause runt disease on 
inoculation into infant homologous hosts (8, 13) or adult F1 hosts (37). 
DISCUSSION 
The  various  findings  reported  in  this  paper  show  that  immunologically 
tolerant mice and rats, bearing "indicator" skin homografts of long standing, 
are superior in several important respects to normal animals for studies on the 
adoptive transfer of transplantation immunity. Most important is their sensi- 
tivity as test subjects, since destruction of hitherto tolerated homografts may 
be complete within 2  to 3  weeks, or less, following transfer of a  few million 
node ceils or leucocytes from actively immunized donors. On the other hand, 
transfer of sensitivity to normal hosts, recognizable in terms of the accelerated 
destruction of  "second set"  test  homografts, requires  the  transfer of what 
may be considered as excessive  numbers of activated  cells,  as Winn (38)  has 
emphasized. 
However, it must not be overlooked that when low dosages of "activated" 
lymphoid cells are transferred, either intraperitoneally or intravenously, from 
a common pool to a  group of tolerant animals, the subsequent survival times 
of their grafts may vary within very wide limits. Quite frequently the grafts on 
some aldmals remain completely unaffected, or may survive a chronic display 
of outward signs of a more or less ineffective level of sensitivity, such as partial 
contracture and alopecia, throughout the standard 100 day observation period. 
The following factors may contribute to this variability in results :--(a)  With 
intraperitoneal  injections  a  variable  amount  of  the  cellular  inoculum may 
sometimes be accidentally deposited in the lumen of the gut, or in some site 
less favorable for the continued viability, dissemination, and expression of the 
immunological potentialities of the cells  (39)  than that afforded by the peri- 
toneal cavity. That this possibility is rather remote is suggested by the variable 
results also obtained when low dosages of activated cells  were transferred by 
the intravenous route. (b) Highly tolerant animals are chimeric with respect to 
their myeloid, and lymphoid tissues and their leucocytes, so that the skin homo- 
grafts they bear comprise only part of the total "target"  cell population con- 
fronting the transferred cells (11, 40). Since our mice had been rendered tolerant 
by neonatal inoculation with various dosages of different cell types, they may 
have differed considerably with respect to both the distribution and numbers of 
alien cells in their various tissues. This may be important in so far as there is 
probably some relationship between the number of  cells  transferred and the 
quantity of target cells they can destroy, at least within a constant time. That 
the level of cell chimerism can influence the facility with which transferred cells 
can bring about the destruction of hitherto tolerated skin homografts is sug- 
gested by recent findings of Michie and Woodruff (41). The consistently prompt R. E. BILLINGB.A~I,  W. K. SILVERS, AND  D. B. W'ILSON  415 
rejections procured by transfer of large numbers of cells also supports this view, 
as do Winn's  (42)  findings  with an  "adoptive transfer"  technique in which 
known dosages of "target"  tumor cells and specifically  "activated" lymphoid 
cells  are mixed  and  then  inoculated  subcutaneously into  appropriate  hosts. 
(c) Where low dosages of immune lymphoid cells are transferred to animals with 
a high degree of cell chimerism, the abundance of antigen confronting them may 
even be sufficient to procure immunological  unresponsiveness on the part of the 
putative attacking cell population. 
The possibility must also remain  on probation that  the existence of some 
degree of cell chimerism  may actually underlie the great facility with which 
tolerant animals  express immunity of adoptive origin.  It ensures exposure of 
the transferred  cells to an additional  antigenic  stimulus almost immediately 
after their introduction into the tolerant host (of. reference 14). Evaluation of 
this possibility requires studies on transfer of sensitivity to non-chimeric  hosts 
bearing vascularized "target" tissue homografts against which they are incapa- 
ble of reacting.  These include adult mice which have been rendered immuno- 
logically unresponsive to skin homografts through neonatal thymectomy (43), 
and  Syrian hamsters bearing homografts in their  immunologically privileged 
cheek pouches, or bearing healthy cheek pouch skin homografts of long standing 
on their chests (44). 
There is nothing inconsistent about the fact that a test skin homograft upon 
an adoptively immunized normal  host may be totally destroyed within 6 days, 
as a  consequence  of a  "second set" type reaction,  whereas even when large 
numbers of activated ceils are transferred  to tolerant hosts,  their  grafts  are 
rarely destroyed before the 9th day. There is a wealth of evidence that healed-in, 
well established grafts are less  vulnerable  to  sensitivity  than  freshly  trans- 
planted ones (cf. reference 45). 
The finding that cells capable of transferring  homograft sensitivity are first 
demonstrable in the blood and regional nodes of A strain mice 6 days after they 
have received homografts of CBA skin has two important implications.  Firstly, 
since orthotopic skin homografts usually elicit histologically  detectable changes 
in the regional nodes, indicative of the inception of an immunological  response, 
within 4 days (46, 47), at least 2 additional days appear to be necessary for the 
production of detectable numbers of activated cells. Secondly, the appearance 
of activated cells in the nodes and blood at approximately the same time sug- 
gests that  these cells must be liberated into the blood very soon after their 
formation in the nodes.  These facts, in conjunction with the finding  that "ac- 
tivated" cells are demonstrable in the blood for hundreds of days after mice 
have rejected skin homografts, may be considered to represent additional cir- 
cumstantial evidence in favor of the thesis that the destruction of vascularized, 
solid tissue homografts, is mediated by blood-borne ceils. Moreover, the almost 
indefinite  persistence of "activated" cells in the blood of mice immunized by 416  TRANSFER  OF  SENSITIVITY  TO  SKIN  HOMOGRAFTS 
means of skin homografts may be considered  to provide a firm basis for the 
belief that  the "second set" reaction is predominantly the outcome of a pre- 
existing  state  of sensitivity  (2).  Although  the  occurrence  of a  secondary or 
anamnesfic response to second set homografts, heightening the level of the pre- 
existing  sensitivity, almost certainly occurs, it probably fails to intervene soon 
enough to affect such grafts (23). 
A sound physiological  basis for the long persistence of activated cells in the 
blood stream of sensitized  animals  is provided by Gowans'  (34, 35)  evidence 
that lymphocytes are long lived cells, probably with a life span of the order of 
100 days, and that these cells undergo a  continuous recirculation from blood 
to lymph, probably via the lymph nodes and efferent lymphatics. 
Although  it is  well  established  that  the majority of the  infiltrating  small 
lymphocyte population in homografts borne by normal hosts, or in skin homo- 
grafts borne by tolerant  hosts rehabilitated  by transfer  of cells from normal 
isologous donors, are of new formation (36, 48), unequivocal evidence that these 
cells are the causal agents of graft destruction has yet to be produced. How- 
ever, recent studies indicate that suspensions  of activated lymphoid cells, in- 
cluding  thoracic duct cells, are capable of destroying homologous target cells 
in vitro (49, 50). So far attempts to demonstrate, by employment of isotoplcally 
labeled  cells,  that  the  infiltrating  mononuclear  cells  in  skin homografts  on 
adoptively immunized animals  are either transferred cells, or their descendants, 
have been unsuccessful  (29, 51).  Studies on the adoptive transfer of delayed 
hypersensitivity to various allergens  in guinea  pigs,  by means of isotopically 
labeled lymphoid cells, have, with one exception (52),  also failed to produce 
evidence of specific localization  of marked cells at antigen challenge  sites (cf. 
references  33 and 53). 
The present studies shed very little light on the fate of the cells transferred 
to tolerant animals.  Whatever the tactics may be whereby transferred leuco- 
cytes from sensitized  donors procure the abolition of tolerance,  they probably 
establish permanent  cell lineages,  or clones,  in  their  new hosts as evidenced 
by the  consistent persistence  of the  transferred  sensitivity for  hundreds  of 
days. 
The findings obtained in the present study concerning the origin, distribution, 
and persistence of blood borne, immunologically  activated cells in mice grafted 
with homologous skin are very similar to those obtained by Brent, Brown, and 
Medawar (2). They have studied a delayed dermal hypersensitivity reaction in 
donor guinea pigs procured by local adoptive transfer of cells from hosts im- 
munized by means of skin homografts. 
By neither  method  of revealing  passively acquired  skin  homograft  sensi- 
tivity have we been able to confirm the finding of Najarian and Feldman (29, 
30), and of Kretschmer and P6rez-Tamayo (54) that transfer of immunologi- 
cally activated lymphoid cells in Millipore  chambers confers  sensitivity upon R. E. BILLINGS,  W. K. SILVERS, AND D, B. WILSON  417 
the host. Russell (55),  too, has been unable to abolish tolerance in mice by 
transfer of cells  in  chambers.  The reason for  this discrepancy is  at present 
obscure. 
SUM'MA_RY 
Mice or rats that have been rendered tolerant of skin homografts from an 
alien donor strain furnish the basis of a very sensitive and objective test system 
for investigating the competence of cellular inocula from specifically immunized 
isologous donors to transfer sensitivity adoptively. 
By means of this test system it has been shown that immunologically "ac- 
tivated" cells, capable of transferring homograft sensitivity, are present in the 
blood, peritoneal exudates, and regional nodes of animals that have rejected 
skin homografts. Leucocytes were as effective as regional node cells. Activated 
cells were first demonstrable in the regional nodes and blood of skin homograft 
recipients at the same time,--on the 6th postoperative day,--suggesting that 
these cells must enter the circulation very soon after their formation in the 
nodes. Moreover, when sensitization was effected by skin homografts, but not 
by means  of splenic  cell  suspensions inoculated intraperitoneally, activated 
cells axe highly persistent, still being demonstrable in both the blood and the 
nodes more than a year after sensitization. 
The finding that thoracic duct cells,  which are almost exclusively lympho- 
cytes, were  just as  effective as leucocytes or  regional nodes in  transferring 
sensitivity in rats formally identifies the cell type responsible for transferring 
sensitivity in the various tissues tested. 
Attempts to transfer sensitivity to homografts in normal mice or tolerant 
mice by means of larger dosages of activated lymphoid cells  sequestered  in 
Millipore chambers inserted intraperitoneally were unsuccessful. 
All this, and other evidence presented,  lends strength to the thesis that skin 
homograft immunity is a cell-mediated reaction. 
The invaluable technical  assistance afforded  by Miss Barbara A. Hodge and Mr. George 
H. Sawchuck  is gratefully  acknowledged. 
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